Genentech San Francisco Vertical Manufacturing Facility Acquisition

United States

Deal value: $320,000,000

Genentech acquired a 400,000 SF vertical manufacturing facility in San Francisco for advanced biologics and cleanroom operations, supporting urban biotech cluster growth.

The acquisition is driven by Genentech's strategic push to consolidate and modernize its advanced biologics manufacturing footprint within a high-density urban biotech cluster. This move reflects a fundamental belief in the long-term growth of urban life sciences hubs and the need for proximity to talent, innovation, and supply chain resilience. The timing aligns with broader industry trends toward onshoring, vertical integration, and securing capacity for next-generation therapies in a competitive market.